grisofulvin 125 mg / 5mL Suspension 120 mL
Comprehensive product details for sourcing and verification.
| NDC 11 | 69097-0361-08 |
|---|---|
| Product NDC | 69097-0361 |
| Generic Drug Name | grisofulvin |
| Brand Name | grisofulvin |
| Manufacturer | Cipla USA Inc. |
| Strength | 125 mg / 5mL |
| Dosage Form | Suspension |
| Drug Type | Oral |
| Package Quantity | 120 mL |
| Package Description | 120 mL in 1 BOTTLE (69097-361-08) |
| Active Ingredients | Griseofulvin |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
grisofulvin 125 mg / 5mL Suspension is tracked under NDC 69097-0361-08 and rolls up into product family 69097-0361. Use this page to confirm the exact presentation before moving into related family or manufacturer pathways.
- Package configuration: 120 mL.
- Manufacturer: Cipla USA Inc..
- Dosage form: Suspension.
- Family size: 1 active presentation.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Drug Shortage Information
Public sources include authoritative public product-label and FDA shortage-program references for griseofulvin oral suspension.
This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
grisofulvin 125 mg / 5mL Suspension 120 mL, NDC 69097-0361-08, is a Cipla USA Inc. 125 mg / 5mL suspension presentation packaged as 120 mL. Historical public shortage information is available for this exact presentation.
NDC search formats
- Canonical NDC 11: 69097-0361-08.
- Digits-only NDC 11: 69097036108.
- Possible 10-digit display formats: 69097-361-08 (6909736108), 69097-0361-8 (6909703618).
Multiple 10-digit display-format aliases can map to the same stored 11-digit billing NDC, so these are shown as search aliases rather than a single asserted package format.
Helpful product links
- Search by brand name: grisofulvin.
- Exact NDC 11: 69097-0361-08.
- Product family NDC: 69097-0361.